ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2025
Role of age in prognostication of hospital mortality in postcardiotomy patients supported with extracorporeal membrane oxygenation.
Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Despite the growing use of venoarterial extracorporeal membrane oxygenation (VA-ECMO), there are still no clearly defined criteria for VA-ECMO initiation in postcardiotomy (PC) patients. Aim: To identify the pre-ECMO risk factors associated with increased hospital mortality, paying special attention to the patients' age. Material and methods: Retrospective review of consecutive adult patients supported with PC ECMO for a 16-year period in a tertiary care center. The primary outcome was all-cause mortality. Logistic regression was performed to identify mortality predictors. To determine the optimal age cut-off that most accurately distinguishes between higher and lower probabilities of mortality, the Youden index was used. Results: A total of 214 patients were enrolled in the final analysis and 55 (25.7%) survived until hospital discharge. Age was a significant mortality predictor with ROC-AUC of 0.596 (0.508-0.685), Conclusions: Our study confirms that advanced age is a prognostic marker of mortality in PC ECMO patients and doubles the mortality risk above 60 years. However, age must be considered alongside other mortality predictors. These findings can significantly contribute to the decision-making process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.